Published in Clin Colon Rectal Surg on September 01, 2014
Fecal Incontinence: Epidemiology, Impact, and Treatment. Clin Colon Rectal Surg (2016) 0.75
Supplementation with dietary fiber improves fecal incontinence. Nurs Res (2001) 2.71
Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology (2009) 2.52
Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med (1983) 2.40
Epidemiology of fecal incontinence: the silent affliction. Am J Gastroenterol (1996) 2.25
Translating clinical research into practice: a randomized controlled trial of exercise and incontinence care with nursing home residents. J Am Geriatr Soc (2002) 2.11
Diagnosis and management of fecal incontinence. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol (2004) 1.90
Quality of life in patients with benign anorectal disorders. Br J Surg (1998) 1.89
Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg (2000) 1.61
Increased drug delivery to the brain by P-glycoprotein inhibition. Clin Pharmacol Ther (2000) 1.60
Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency. Dig Dis Sci (1982) 1.48
Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults. Cochrane Database Syst Rev (2012) 1.45
Mechanism of the antidiarrheal effect of loperamide. Gastroenterology (1984) 1.33
Anorectal sensorimotor dysfunction in fecal incontinence and diabetes mellitus. Modification with biofeedback therapy. N Engl J Med (1984) 1.30
Prevalence of bowel dysfunction in multiple sclerosis. A population survey. Gastroenterology (1990) 1.25
Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology (1980) 1.21
Urinary and faecal incontinence in community-residing elderly women. Age Ageing (1992) 1.20
Urinary and fecal incontinence in nursing home residents. Gastroenterol Clin North Am (2008) 1.14
Fecal incontinence in the institutionalized elderly: incidence, risk factors, and prognosis. Am J Med (1999) 1.12
Incontinence in institutions: costs and contributing factors. CMAJ (1992) 1.11
Long-term outcome and safety of transanal colonic irrigation for neurogenic bowel dysfunction. Spinal Cord (2008) 1.09
Loperamide. J Pain Symptom Manage (2011) 1.06
Open study of low-dose amitriptyline in the treatment of patients with idiopathic fecal incontinence. Dis Colon Rectum (2000) 1.03
Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut (2001) 1.02
Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis. J Neurol Neurosurg Psychiatry (2000) 1.01
Effects of loperamide oxide on gastrointestinal transit time and anorectal function in patients with chronic diarrhoea and faecal incontinence. Scand J Gastroenterol (1997) 1.00
Why do patients with faecal impaction have faecal incontinence. Gut (1986) 1.00
A controlled trial of an intervention to improve urinary and fecal incontinence and constipation. J Am Geriatr Soc (2010) 0.99
Cholestyramine--a useful adjunct for the treatment of patients with fecal incontinence. Int J Colorectal Dis (2007) 0.99
Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev (2003) 0.99
Biofeedback treatment of fecal incontinence in geriatric patients. J Am Geriatr Soc (1985) 0.98
Fecal incontinence in the elderly: FAQ. Am J Gastroenterol (2012) 0.97
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther (2001) 0.95
Topical phenylephrine increases anal sphincter resting pressure. Br J Surg (1999) 0.95
Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 5: the pharmacokinetics of loperamide in rats and man. Arzneimittelforschung (1974) 0.95
Effects of prompted voiding on fecal continence among nursing home residents. J Am Geriatr Soc (1996) 0.93
Anorectal dysfunction in multiple sclerosis: a systematic review. ISRN Neurol (2012) 0.89
Manometric correlations of anorectal dysfunction and biofeedback outcome in patients with multiple sclerosis. Mult Scler (2007) 0.89
Loperamide improves anal sphincter function and continence after restorative proctocolectomy. Dig Dis Sci (1994) 0.88
Impairment of anorectal function in diabetes mellitus parallels duration of disease. Dis Colon Rectum (1999) 0.87
Topical phenylephrine in the treatment of radiation-induced faecal incontinence. Clin Oncol (R Coll Radiol) (2005) 0.87
Randomized, controlled trial of topical phenylephrine for fecal incontinence in patients after ileoanal pouch construction. Dis Colon Rectum (2000) 0.85
Medical management of fecal incontinence. Gastroenterology (2004) 0.85
The efficacy and adverse effects of topical phenylephrine for anal incontinence after low anterior resection in patients with rectal cancer. Int J Colorectal Dis (2007) 0.85
Efficacy of methylcellulose and loperamide in managing fecal incontinence. Acta Obstet Gynecol Scand (2009) 0.85
Pathophysiology and management of bowel dysfunction in multiple sclerosis. Eur J Gastroenterol Hepatol (2001) 0.85
Fibre supplementation in addition to loperamide for faecal incontinence in adults: a randomized trial. Colorectal Dis (2008) 0.83
Bowel biofeedback treatment in patients with multiple sclerosis and bowel symptoms. Dis Colon Rectum (2011) 0.82
Pharmacotherapy for fecal incontinence: a review. Dis Colon Rectum (2007) 0.82
Fecal incontinence in the elderly patient. Am J Med (2003) 0.79
Transanal irrigation for bowel symptoms in patients with multiple sclerosis. Dis Colon Rectum (2012) 0.79